Niteroi, Brazil

Paulo De Assis Melo


Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Paulo De Assis Melo

Introduction

Paulo De Assis Melo is an accomplished inventor based in Niteroi, Brazil. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds with therapeutic properties. His work focuses on creating innovative solutions for medical challenges, especially in treating heart conditions.

Latest Patents

Paulo De Assis Melo holds a patent for a compound known as Thienylhydrazon, which exhibits digitalis-like properties. This invention is particularly noteworthy for its positive inotropic effects, which enhance the strength of heart muscle contractions. The compound is characterized by a specific formula, where R is selected from hydrogen, alkyl groups of 1 to 6 carbon atoms, unsubstituted phenyl, and substituted phenyl. Additionally, the invention includes a novel method for synthesizing 3,4-methylenedioxybenzoyl-2-thienylhydrazone, also known as LASSBio-294. This compound is beneficial for treating congestive heart failure and muscle fatigue, while lacking the toxic effects commonly associated with digitalis glycosides.

Career Highlights

Paulo De Assis Melo is affiliated with the University System of Maryland, where he continues to engage in research and development. His work has garnered attention for its potential impact on cardiac health and muscle function. With a focus on innovative pharmaceutical solutions, he has established himself as a key figure in his field.

Collaborations

Paulo has collaborated with notable colleagues, including Roberto Takashi Sudo and Edson X Albuquerque. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Paulo De Assis Melo's contributions to the field of pharmaceuticals highlight the importance of innovation in addressing medical challenges. His work on Thienylhydrazon and its applications in treating heart conditions exemplifies the potential of scientific research to improve health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…